Woman and Man
- | Country :
- Chile
- Romania
- Canada
- The 13 others...
- | organs : -
- | Specialty : -
Extract
This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to compare the PFS, OS, ORR, DR, safety and tolerability, and kidney specific symptoms/health outcome measurements of tivozanib and sorafenib.
Inclusion criteria
- ADVANCED RENAL CELL CARCINOMA